US jury in Luigi Mangione murder trial to remain anonymous

A U.S. jury in the murder trial of Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, will remain anonymous following a ruling by New York State Judge Gregory Carro. The decision comes as the highly anticipated state trial approaches, set to begin next month. The ruling underscores the unprecedented nature of the case, which has drawn widespread public and media attention since Thompson's December 2024 shooting in Manhattan. Carro made the announcement during a hearing earlier this week, stating that the identities of the jurors would not be disclosed to the public. This move follows concerns that jurors might face harassment or intimidation due to the case's high profile. While anonymous juries are rare in American criminal proceedings, they are occasionally used in cases involving significant public interest or potential threats to juror safety. The judge also ordered that an overflow courtroom be prepared for the public and press if the primary courtroom fills up, reflecting the intense scrutiny surrounding the trial. Mangione, 28, has pleaded not guilty to state charges including murder, weapons possession, and forgery related to the killing of Thompson, who was shot outside a hotel in Midtown Manhattan as he attended an investor conference. The incident triggered a nationwide response, with footage of the shooting rapidly circulating online and sparking a five-day manhunt that ended with Mangione’s arrest in Pennsylvania. Authorities discovered that the words “delay,” “deny,” and “depose” were inscribed on the ammunition linked to the attack, phrases often associated with criticisms of insurance companies' practices. Prosecutors have assembled a robust case, citing hundreds of hours of surveillance video, fingerprints, DNA evidence, a mobile phone, and a gun matching the ballistic evidence from the crime scene. They also intend to present a notebook allegedly belonging to Mangione, which prosecutors claim contains references to targeting a health insurance executive and expressing opposition to what they describe as a “deadly, greed fueled health insurance cartel.” Earlier this year, Carro permitted the admission of both the 3D-printed pistol and the notebook as evidence in the trial. Mangione’s defense team has yet to reveal specific strategies to challenge the prosecution’s case, though they briefly considered using an “extreme emotional disturbance” defense in June. Under New York law, such a defense could have led to a conviction for manslaughter instead of murder, potentially reducing the sentence from life imprisonment to up to 25 years. However, the defense withdrew the notice shortly thereafter, with attorney Karen Friedman Agnifilo informing the court that Mangione was retracting the motion “at this time.” Separately, Mangione faces federal charges arising from the same incident. Federal murder and weapons charges were dismissed in January on legal grounds, removing the possibility of the death penalty. Nevertheless, he still confronts federal stalking charges that could lead to a life sentence upon conviction. His federal trial is scheduled to commence in January, with sentencing set for December 18. In a recent development, Mangione entered a guilty plea in federal court to two charges: interstate stalking resulting in death and stalking through use of interstate facilities resulting in death. During the hearing, Mangione stated he researched UnitedHealthcare’s investor conference and posed as an investor to gather information, which he then used to target Thompson. He admitted to the court that he shot Thompson, acknowledging the illegality of his actions. The plea was described by U.S. Attorney Jamie McDonald as a “deliberate, calculated and premeditated” act aimed at drawing public attention to his grievances with certain businesses. McDonald emphasized that no grievance, political belief, or ideological cause justifies murder, adding that there can be no celebrity status in assassination. The guilty plea allows prosecutors to seek the maximum allowable punishment under federal law, which is life imprisonment. Mangione’s attorneys argued that their client accepted full responsibility for the killing while contending he has been unfairly treated by facing both federal and state charges. They filed a motion requesting the dismissal of state charges based on New York’s double-jeopardy law, which prevents individuals from being tried twice for the same offense. However, Manhattan District Attorney Alvin Bragg has expressed firm commitment to pursuing justice for Thompson’s family, indicating resistance to the motion. Thompson, a 50-year-old father of two who managed the country’s largest healthcare insurer, was killed on a New York City street in December 2024. The subsequent manhunt culminated in Mangione’s arrest at a McDonald’s restaurant in Pennsylvania five days later. As the state trial looms, the case continues to reflect broader societal tensions regarding healthcare costs and the role of private insurers in the United States.